Financial Data and Key Metrics Changes - In Q4 2024, consolidated revenue was $150.4 million, down 3.8% year-over-year [31] - Full-year 2024 consolidated revenue declined 8.8% to $572.5 million compared to $627.6 million in 2023 [33] - Adjusted gross margin for Q4 2024 was 49.6%, up from 48.8% in Q4 2023, reflecting operational efficiency [35] - GAAP net loss for Q4 2024 was $41.9 million, or $0.59 per diluted share, compared to a net loss of $15 million, or $0.22 per diluted share in the same period last year [39] Business Line Data and Key Metrics Changes - Product revenue in Q4 2024 fell by 4.8% to $105.1 million, with systems revenue down 1.5% to $46.7 million [31] - Consumable revenue in Q4 2024 was $58.4 million, down 7.3% year-over-year [32] - Service revenue for Q4 2024 was $45.3 million, relatively flat compared to $45.9 million in Q4 2023 [32] - Full-year consumables revenue increased by 2.3% to $251.7 million in 2024 compared to $246 million in 2023 [33] Market Data and Key Metrics Changes - 36% of revenues in 2024 came from manufacturing, up from 34% in 2023 [10] - The company expects consumables revenue to increase in 2025 compared to 2024 [34] Company Strategy and Development Direction - The company is focused on enhancing leadership in additive manufacturing and targeting full-scale production applications [9] - A $120 million investment from Fortissimo Capital is expected to close in Q2 2025, which will support growth through organic investment and acquisitions [13] - The company aims to maintain R&D resources while right-sizing the business for current market conditions [51] Management's Comments on Operating Environment and Future Outlook - Management acknowledges ongoing macroeconomic challenges but remains optimistic about long-term growth in additive manufacturing [50] - The company expects revenue in 2025 to be between $570 million and $585 million, with sequential growth throughout the year [45] - Non-GAAP gross margin for 2025 is projected to be between 48.8% and 49.2% [46] Other Important Information - The company ended Q4 2024 with $150.7 million in cash and equivalents, compared to $144 million at the end of Q3 2024 [44] - The company generated $7.4 million of cash from operations in Q4 2024, compared to a cash use of $7.7 million in the same quarter last year [42] Q&A Session Summary Question: Market conditions and revenue cadence for 2025 - Management noted that while there are short-term constraints, customer feedback remains positive, and they expect gradual revenue growth as conditions improve [56][58] Question: Gross margin guidance for 2025 - Management indicated that gross margins are expected to remain solid, with improvements from restructuring efforts and product mix [63][64] Question: Organic revenue growth and FX impacts - Management stated that divestitures and FX impacts are minimal, with a focus on maintaining a strong position in the U.S. market [75][76] Question: Denture market opportunity - The company highlighted its innovative denture solutions and plans to capture a significant share of the $2.5 billion market opportunity by 2028 [79][80] Question: Consumables revenue decline - Management explained that Q4 was considered an outlier and expects consumables revenue to rebound in 2025 [88] Question: Acquisition targets - The company is focused on acquisitions that enhance shareholder value, with a clear strategy to capitalize on market opportunities [97][102] Question: 2025 market verticals and pipeline visibility - Management expressed confidence in dental, aerospace, and tooling markets, while acknowledging current market softness [112][115]